Technology And Equipment Tenders

Completion not Excl. Pharmaceutical Discount Club. According to Section 130A (8) Sgb V by an Open-House Model to the Active Ingredient Beclometason/Formoterol (Atc Code According to Who: R03ak08)

Completion not Excl. Pharmaceutical Discount Club. According to Section 130A (8) Sgb V by Means of an Open House Model to the Active Ingredient Dornase Alfa (Atc Code According to Who: R05cb13)

Open House Biologics Discount Agreements 2025-02 - Rituximab (Dosage Form for Subcutaneous Injection)

Conclusion not Excluding Drug Discount Agreement. According to Section 130A Paragraph 8 Sgb V by Means of an Open House Model for the Active Ingredient Aripiprazole for Parenteral Administration (Atc Code According to Who: N05ax12)

Conclusion not Excluding Drug Discount Agreement. According to Section 130A Paragraph 8 Sgb V through an Open House Model for the Active Ingredient Natalizumab (Atc Code According to Who: L04ag03)

Wiesestrasse Ba 8 - Los 0 - Los 10.1

Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130 a Paragraph 8 Sgb V in the Period from March 1St, 2025 to December 31St, 2026

Dynamic Procurement System for Purchasing Various it Services

Open House Drug Discount Agreements Nilotinib, Atc L01ea03 (Excludes Nilotinib Dispersed in Applesauce, Unless the Manufacturer Enjoys Patent Protection for This)

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V on Active Ingredients (Medicines) - Vv 81